- Home
- IPDN vs LGVN Comparison
IPDN vs LGVN Comparison
Compare IPDN & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- LGVN
- Stock Information
- Founded
- IPDN 2003
- LGVN 2014
- Country
- IPDN United States
- LGVN United States
- Employees
- IPDN N/A
- LGVN N/A
- Industry
- IPDN EDP Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- IPDN Technology
- LGVN Health Care
- Exchange
- IPDN Nasdaq
- LGVN Nasdaq
- Market Cap
- IPDN 11.1M
- LGVN 30.0M
- IPO Year
- IPDN 2013
- LGVN 2021
- Fundamental
- Price
- IPDN $0.89
- LGVN $2.05
- Analyst Decision
- IPDN
- LGVN Strong Buy
- Analyst Count
- IPDN 0
- LGVN 2
- Target Price
- IPDN N/A
- LGVN $8.00
- AVG Volume (30 Days)
- IPDN 236.3K
- LGVN 393.9K
- Earning Date
- IPDN 11-12-2024
- LGVN 11-08-2024
- Dividend Yield
- IPDN N/A
- LGVN N/A
- EPS Growth
- IPDN N/A
- LGVN N/A
- EPS
- IPDN N/A
- LGVN N/A
- Revenue
- IPDN $7,319,905.00
- LGVN $1,229,000.00
- Revenue This Year
- IPDN N/A
- LGVN $161.78
- Revenue Next Year
- IPDN N/A
- LGVN $8.62
- P/E Ratio
- IPDN N/A
- LGVN N/A
- Revenue Growth
- IPDN N/A
- LGVN 39.34
- 52 Week Low
- IPDN $0.42
- LGVN $0.77
- 52 Week High
- IPDN $3.01
- LGVN $23.90
- Technical
- Relative Strength Index (RSI)
- IPDN 59.33
- LGVN 52.20
- Support Level
- IPDN $0.77
- LGVN $1.76
- Resistance Level
- IPDN $0.97
- LGVN $2.26
- Average True Range (ATR)
- IPDN 0.14
- LGVN 0.12
- MACD
- IPDN -0.00
- LGVN 0.05
- Stochastic Oscillator
- IPDN 35.95
- LGVN 58.00
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.